$-2.46
(Market cap
$4,379 Mln
Revenue (TTM)
$2,159 Mln
P/E Ratio
147.1
P/B Ratio
2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
18.8
-
Debt to Equity
0.6
-
Book Value
$--
-
EPS
$1.2
-
Face value
--
-
Shares outstanding
25,007,038
10 Years Aggregate
CFO
$1,216.36 Mln
EBITDA
$1,517.48 Mln
Net Profit
$418.94 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ICU Medical (ICUI)
| 17.3 | -0.7 | 28.3 | 31.8 | 4.9 | -3.9 | 2.8 |
|
BSE Sensex
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
ICU Medical (ICUI)
| -8.1 | 55.0 | -36.7 | -33.6 | 10.7 | 14.6 | -18.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ICU Medical (ICUI)
|
167.4 | 4,378.7 | 2,159.4 | 30.1 | 2.0 | 1.4 | 147.1 | 2.0 |
| 61.4 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.9 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 58.6 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 180.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.9 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 89.1 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 322.0 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 168.2 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout ICU Medical (ICUI)
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave,... MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California. Read more
-
CEO & Chairman of the Board
Mr. Vivek Jain
-
CEO & Chairman of the Board
Mr. Vivek Jain
-
Headquarters
San Clemente, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ICU Medical (ICUI)
What is the current share price of ICU Medical Inc (ICUI) Today?
The share price of ICU Medical Inc (ICUI) is $167.39 (NASDAQ) as of 03-Sep-2026 13:34 EDT. ICU Medical Inc (ICUI) has given a return of 4.94% in the last 3 years.
What is the current PB & PE ratio of ICU Medical Inc (ICUI)?
The P/E ratio of ICU Medical Inc (ICUI) is 147.14 times as on 28-Aug-2026, a 231 premium to its peers’ median range of 44.46 times.
The P/B ratio of ICU Medical Inc (ICUI) is 2.03 times as on 28-Aug-2026, a 46 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
4,811.60 |
1.66 |
2024 |
-32.29 |
1.93 |
2023 |
-81.19 |
1.13 |
2022 |
-50.85 |
1.81 |
2021 |
50.18 |
3.20 |
What is the 52 Week High and Low of ICU Medical Inc (ICUI)?
The 52-week high and low of ICU Medical Inc (ICUI) are Rs 192.85 and Rs 112.50 as of 04-Sep-2026.
What is the market cap of ICU Medical Inc (ICUI)?
ICU Medical Inc (ICUI) has a market capitalisation of $ 4,379 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in ICU Medical Inc (ICUI)?
Before investing in ICU Medical Inc (ICUI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.